ValiRx Finland Overview

  • Founded
  • 2008

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

ValiRx Finland General Information


Provider of medical and clinical services. The company offers research and development services for therapeutics, it manages clinical work for VAL 201, a peptide for the treatment of refractory prostate cancer.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Primary Office
  • Elektroniikkatie 3
  • 90590 Oulu
  • Finland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ValiRx Finland Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ValiRx Finland‘s full profile, request access.

Request a free trial